Novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan

By loading recombinant human elastin, quercetin and triclosan in absorbable sutures, combined with dopamine self-oxidation technology, the shortcomings of sutures in mechanical properties and antibacterial and scarring are solved, and faster wound recovery and reduction are achieved Scar formation significantly improves the biocompatibility and healing effect of sutures.

CN118986441APending Publication Date: 2024-11-22NORTHWEST UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410834671.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-26
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing sutures are difficult to meet the needs of mechanical properties and antibacterial and anti-scars in clinical surgery, resulting in wound infection and scar formation, affecting the healing effect.

Method used

Using multi-functional absorbable sutures with recombinant human elastin, quercetin and triclosan, the dopamine self-oxidation loading technology combines antibacterial and antiscar drugs with elastin to improve the biocompatibility and healing of sutures. efficiency.

Benefits of technology

It significantly reduces the risk of wound infection, promotes wound recovery, reduces scar formation, and improves the antibacterial and anti-scar properties of sutures, enhancing the tissue healing ability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118986441A_ABST
    Figure CN118986441A_ABST
Patent Text Reader

Abstract

The invention discloses a novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan. The suture can be loaded with quercetin, recombinant human elastin or triclosan. The absorbable surgical suture has good biocompatibility, has degradable and absorbable functions, has a remarkable effect in the aspect of inhibiting bacteria, has antibacterial and anti-scar functions, can realize rapid healing of wounds and avoid repeated medication and infection, can be applied to the clinical fields of wound recovery, medical beauty and the like, and has a good treatment effect on skin tightening, wound healing, wound healing and the like. Clinical wound recovery and wound scar removal are of great significance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biomedicine, and specifically relates to a novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan. Background Art

[0002] With the development of the chemical industry, a series of sutures made of polyamide, polypropylene, polyglycolide, etc. have been developed and are widely used due to their excellent mechanical properties and biocompatibility.

[0003] In clinical surgery, the most suitable sutures need to be matched to different wounds. According to whether they can be absorbed, they can be divided into non-absorbable and absorbable sutures. Among natural sutures, silk sutures, namely silk, are still used in clinical practice. However, as a protein fiber, silk can cause bacterial growth during the suturing process, and the gaps in its own woven structure are more likely to adhere to bacteria, causing wound infection and affecting wound healing.

[0004] Common materials for absorbable sutures are poly-p-dioxanone (PPDO), polycaprolactone (PCL), polyglycolic acid (PGA) and its copolymers. Among them, PPDO is an aliphatic polyester obtained by ring-opening polymerization with p-dioxanone (PDO) as the raw material. It has the characteristics of non-toxicity, good biocompatibility, good biodegradability and flexibility, high mechanical strength, etc., and is suitable for wounds with a long healing time. Due to its poor flexibility and the rapid decrease in strength in the body environment, it is now mostly used in copolymerization with lactide. Although the materials of sutures are diverse, there is currently no material that can simultaneously meet the mechanical performance requirements of medical surgery. Sutures will inevitably have side effects during use, that is, causing postoperative infection.

[0005] With the continuous research on sutures worldwide, the development of sutures, such as drug-loaded sutures and antibacterial sutures, has provided a new direction for its development in the field of biomedicine and has broad development prospects. Chen et al. impregnated silk threads in a polycaprolactone coating containing levofloxacin hydrochloride. The resulting sutures showed excellent antibacterial effects on Staphylococcus aureus and Escherichia coli, and could effectively prevent bacterial adhesion. Zhang et al. loaded chitosan / gelatin-tannic acid (CS / GE-TA) on sutures to prepare multifunctional suture TA100, which showed excellent anti-inflammatory and antibacterial properties.

[0006] In order to achieve better clinical suturing effects, researchers have developed absorbable sutures with barbs. Barbed sutures are arranged in a certain longitudinal orientation on the surface of the suture, so that the suture and the tissue have an "anchoring" effect, that is, the suture will not move freely when the suture moves in the opposite direction. By removing the knots and dispersing the tension of the wound, the suturing efficiency is further improved. In addition, the stress distribution of the barbed suture is uniform, and the operation is simple and fast. At the same time, the performance of barbed sutures and smooth sutures is similar, but the barbed sutures provide certain mechanical support for the tissue within 8 weeks (the time for complete degradation is more than 24 weeks), and are more suitable for tissues that require a long time (within 8 weeks) to repair and heal. Therefore, the development of antibacterial absorbable sutures is of great clinical significance in order to avoid wound infection and promote wound healing.

[0007] Elastin is a protein that plays a vital role in the elastic movement and deformation resistance of tissues in human skin, arteries, ligaments and other tissues. Elastin has good biocompatibility and can regulate cell functions, such as promoting cell proliferation, differentiation and migration. Elastin sequences have two types of domains: hydrophobic and hydrophilic. It is generally believed that elastin interacts with cells through its hydrophobic domain. Natural elastin is widely used in medical tissue engineering, and elastin-like proteins are also widely used due to their excellent performance. Urry's laboratory synthesized elastin-like proteins (ELPs) based on the hydrophobic region of natural bovine elastin, which are mainly composed of short and repeated sequences VPGXG (X is any amino acid except Pro) in series. Therefore, according to needs, amino acid sequences with different functions can be introduced into polypeptide sequences to design and construct corresponding ELPs, which has better application prospects. ELPs are a protein obtained by genetic engineering, but still retain some of the activity of natural elastin - the characteristics of self-assembly under physiological conditions and the classic temperature-sensitive characteristics, and have reversible phase change behavior.

[0008] ELPs are mainly obtained by natural extraction, chemical synthesis and recombinant DNA technology. However, natural elastin extracted from animal sources has immunogenicity and viral risks, and has a single sequence; while chemically synthesized elastin has potential, it is limited by the difficulty in controlling its polypeptide chain length and synthesis conditions, as well as the challenge of high cost. Therefore, recombinant DNA technology combined with genetic engineering to synthesize larger ELP polymers with a specific molecular weight has become the most convenient method. This method has the advantages of low cost for preparing elastin, easy large-scale production, and elimination of immune and viral risks. In addition, ELPs are easily expressed in Escherichia coli (E. coli) in the form of plasmid-borne genes, with relatively high yields (growth rate can reach 500 mg / L).

[0009] ELPs have outstanding characteristics such as simple controllability of amino acid sequences, temperature phase transition, good solubility, and excellent biocompatibility. They show great potential in forming hydrogels and network scaffolds, making them ideal for promoting cell attachment and proliferation. They have been widely used in biomedical fields such as cell culture and tissue regeneration. In addition, their hydrogel morphology also plays an important role in the controlled release of drugs, providing a new solution for drug delivery. Previous studies have found that ELPs have good biocompatibility. Loading ELPs with good biological activity into sutures can increase tissue compatibility after surgery and promote wound healing. However, elastin cannot be effectively loaded into it by simply soaking it in protein. Therefore, dopamine is used as an intermediate to first chemically load it into absorbable sutures, and then dopamine (DA) adhesion protein is used to load it on the line. DA is a molecule produced by marine mussels. It can be oxidized and polymerized in weak alkaline and aerobic environments to generate polydopamine (PDA). The catechol structure on PDA has strong reactivity and can be loaded into it regardless of the surface chemical properties of the solid material, which is conducive to modifying and modifying various scaffold materials and giving them various biological functions, such as promoting cell proliferation and adhesion, tissue regeneration, etc. Biomaterials with PDA coatings have been widely used in various tissue engineering fields due to their excellent performance. Gao et al. loaded PDA onto PLGA porous microspheres to prepare PLGA-PDA porous microspheres. These microspheres can effectively adsorb exosomes and show a high exosome retention rate at the treatment site. In addition, they maintained the release of exosomes for 21 days and effectively induced vascularized bone regeneration in rat skull defects. Wei et al. designed a microcomposite material consisting of a methylprednisolone polymer core and a polydopamine shell. The study found that the material can effectively neutralize excessive cytokines in a broad spectrum manner within 1 day after spinal cord injury and effectively reduce the secretion of new inflammatory cytokines, prevent the recruitment of macrophages and protect the injured spinal cord, which helps to restore motor function.

[0010] In order to make sutures play a role not only in enhancing cell growth and tissue regeneration, but also in preventing wound infection and removing scars, it has become a demand for clinical surgical treatment to make sutures have antibacterial and anti-scar effects. The antibacterial drug triclosan (TCS) is a powerful drug that can reduce wound infection. It has an inhibitory effect on many common bacteria by inhibiting the synthesis of fatty acids in the bacterial growth process. Triclosan is widely used in various biomaterials due to its excellent antibacterial effect, such as loading triclosan to chitosan-supported adhesive resin. Since 2002, the U.S. Food and Drug Administration has certified that triclosan-coated polylactide 910 suture material can be effectively used as an antibacterial surgical suture, and triclosan-coated sutures have come into being. Existing evidence shows that triclosan-coated sutures have a significant antibacterial effect and can effectively reduce the incidence of surgical site infection in abdominal incisions in general surgery and reduce bacterial infection.

[0011] Quercetin is a natural flavonoid compound that is widely found in vegetables, fruits and Chinese herbal medicines. Flavonoid compounds contain a very large group of natural products, which are characterized by containing a C6-C3-C6 skeleton structure. The STAT3 signaling pathway plays an important role in the formation of keloids. Previous studies have shown that quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting the STAT3 signaling pathway. Quercetin can also reduce the expression levels of STAT3 and p-STAT3 proteins in keloid fibroblasts, suggesting that quercetin may inhibit the proliferation of keloid fibroblasts by inhibiting the STAT3 signaling pathway. Summary of the invention

[0012] In order to overcome the deficiencies of the above-mentioned prior art, the purpose of the present invention is to provide a novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan, and antibacterial drugs, recombinant human elastin that promotes healing, and anti-scar drugs are loaded on the absorbable suture in the form of dopamine. The suture not only has the traditional wound suture function, but also has multiple functions such as antibacterial and anti-scar to promote rapid wound healing, which can improve the wound recovery cycle and the efficiency of scar removal, and can prevent wound infection.

[0013] In order to achieve the above object, the technical solution adopted by the present invention is: A novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan, characterized in that the absorbable suture, dopamine, the antibacterial drug triclosan, the recombinant human elastin and the anti-scar drug are loaded by biophysical and chemical means; dopamine is loaded on the absorbable suture by auto-oxidation and then mixed with the antibacterial drug triclosan, the recombinant human elastin and the anti-scar drug; and the protein and drug loading on the suture is adjusted by the number and time of immersion in a dopamine solution.

[0014] The medicine is one or more of antibacterial medicine and anti-scar medicine.

[0015] The sutures described have different structures and can be smooth absorbable sutures or barbed absorbable sutures.

[0016] The loading method is to self-oxidize dopamine into polydopamine, which specifically includes the following steps: first, immersing the material in a dopamine solution (10 mM Tris buffer, pH=8.5), reacting in a 37°C constant temperature incubator for 24 hours to attach polydopamine (PDA) to the surface of the suture, then washing three times with ddH2O, and performing ultrasonic treatment for 5 minutes each time to remove unattached dopamine to obtain PDA@suture, and then immersing the material in a protein solution and a drug solution in turn, and then air-drying to obtain a multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan.

[0017] The recombinant human elastin can enhance drug loading, enhance the adhesion of absorbable sutures, and promote the proliferation of epidermal and endothelial cells.

[0018] The triclosan is a kind of antibacterial drug or a kind of antibacterial protein drug.

[0019] The antibacterial drug is one of triclosan, ciprofloxacin, ofloxacin, rifampicin penicillin and amoxicillin.

[0020] The quercetin is a kind of anti-scar drug.

[0021] The recombinant human elastin component includes elastin and tag protein, wherein the tag protein that plays a purification role is one or more of HIS tag, SUMO tag or GST tag; wherein the elastin is a recombinant human full-length or partial functional domain natural elastin or a recombinant human elastin-like protein.

[0022] The recombinant human elastin may be a recombinant human elastin-like protein, and the elastin-like protein may be a repeating sequence of a natural elastin protein in a partial functional domain or a repeating sequence of a natural elastin polypeptide.

[0023] The preparation of the recombinant human elastin comprises the following steps: The following steps are involved: Step 1: Synthesize the designed recombinant human elastin gene sequence; Step 2: Double enzyme digestion of the synthesized gene fragment and the vector pET28a(+); Step 3: Recover the target fragment after double enzyme digestion by gel recovery; Step 4: Connect the recovered target fragments, then perform plate screening to obtain positive clones, and sequence to detect whether they are completely correct; Step 5: Shake the positive clones with correct sequencing and extract the plasmids, which are then introduced into competent E. coli (BL21(DE3)) by heat shock for plating culture. The competent cells can express proteins. Step 6: Pick the colonies after transformation and culture them. When the OD600 of the bacterial solution is 0.6-0.8, add IPTG inducer to induce for 4-6 hours. Then collect the bacterial solution and centrifuge to obtain bacterial sludge for use; Step 7: Lyse the bacterial sludge, ultrasonically disrupt it, and select different purification methods to separate and purify the protein according to whether the protein is in the supernatant or precipitate; Step 8: The purified protein is desalted and freeze-dried to obtain freeze-dried protein.

[0024] The vector may also be selected from other prokaryotic expression vectors or eukaryotic expression vectors in vitro, and the expression host may be selected from prokaryotic cells and eukaryotic cells depending on the expression vector.

[0025] A multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan is used in skin tightening, wound recovery and wound scar removal.

[0026] Compared with the prior art, the present invention has the following beneficial effects: The improved absorbable suture of the present invention has good biocompatibility, no death cases in animal functional and safety experiments, no significant difference in cell proliferation and other aspects relative to the control group, and no necrosis symptoms in the tissue; the improved absorbable suture of the present invention can inhibit the growth of Escherichia coli and Staphylococcus aureus, significantly reduce the infection in the tissue, and actively promote the repair of the wound surface; the improved absorbable suture of the present invention can inhibit scar formation, and can also prevent infection while tightening the skin; the present invention can reduce the infection risk of postoperative wounds and damaged wounds, and can accelerate the process of wound recovery. The present invention is of great significance in the fields of skin tightening, wound recovery, and wound scar removal. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 The present invention is a schematic diagram of the process of a novel multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan in an embodiment of the present invention; wherein 1-A includes an absorbable suture, dopamine, recombinant human elastin that promotes wound healing, and the antibacterial drug triclosan; 1-B includes an absorbable suture, dopamine, recombinant human elastin that promotes wound healing, the antibacterial drug triclosan, and the anti-scar drug quercetin.

[0028] Figure 2The plasmid map and colony clone map for obtaining recombinant human elastin in the present invention take the recombinant elastin-like gene as an example; 2-A is the recombinant human elastin plasmid map; 2-B is the colony clone map after transformation.

[0029] Figure 3 The SDS-PAGE and Western-Blot images of the induced expression of the recombinant human elastin in the prokaryotic system of the present invention are taken as an example of the recombinant elastin-like gene; wherein M is a protein marker; wherein 3-A is an SDS-PAGE image of induced expression, 1 before induction, 2 after induction, 3 ultrasonic supernatant, 4 ultrasonic precipitation; wherein 3-B is a WB image.

[0030] Figure 4 The SDS-PAGE gel electrophoresis diagram and Western-Blot diagram of the recombinant human elastin purified by nickel column in the present invention; wherein 4-A: Coomassie brilliant blue staining of the recombinant human elastin purified by nickel column; M: Marker; 1. stock solution before purification induction; 2. supernatant after induction; 3. sample flow-through; 4. impurity peak 1; 5. impurity peak 2; 6. target peak 1; 7. target peak 2; 4-B: Western Blot of the recombinant human elastin purified by nickel column; M: Marker; 1. stock solution before purification induction; 2. supernatant after induction; 3. sample flow-through; 4. impurity peak 1; 5. impurity peak 2; 6. target peak 1; 7. target peak 2.

[0031] Figure 5 This is the freeze-dried sample of the recombinant human elastin in the present invention.

[0032] Figure 6 The macroscopic morphology of the absorbable suture before and after loading in the present invention is shown in Figure 6-A, taking the absorbable suture with barbs as an example. 6-B: absorbable suture before loading; 6-C: dopamine loading; 6-D: dopamine loading / elastin loading; 6-D: dopamine loading / elastin loading / triclosan loading.

[0033] Figure 7 The electron microscope images of the absorbable suture thread of the present invention before and after loading.

[0034] Figure 8 The figures are the test results of the inhibition effect of the improved absorbable suture thread on bacteria in the present invention; 8-A is the inhibition zone; 8-B is the statistical diagram of the area of ​​the inhibition zone at different times.

[0035] Fig. 9 This is the test result of cell compatibility in the present invention.

[0036] Fig.10The macroscopic morphology of the improved absorbable suture in the present invention before and after subcutaneous sampling of animals is shown in Figure 10-A, which is an improved absorbable suture with barbs; and Figure 10-B, which is an improved absorbable suture.

[0037] Fig.11 The present invention is a histochemical result of tightening the skin under the skin of animals using the improved absorbable barbed suture thread. DETAILED DESCRIPTION

[0038] The present invention is further described below in conjunction with embodiments and drawings, but the present invention is not limited to the following embodiments.

[0039] like Figure 1 As shown: a novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan in an embodiment of the present invention is characterized in that the multifunctional improved absorbable surgical suture is obtained by loading absorbable suture, dopamine, antibacterial drug triclosan, recombinant human elastin and anti-scar drug in a certain order by biophysical and chemical methods; the recombinant human elastin component includes elastin and tag protein, wherein the tag protein that plays a purification role is one or more of HIS tag, SUMO tag or GST tag; wherein the elastin is a recombinant human full-length or partial functional domain natural elastin or a recombinant human elastin-like protein; the recombinant human elastin can be a recombinant human elastin-like protein, and the elastin-like protein can be a repeating sequence of a partial functional domain natural elastin or a repeating sequence of a natural elastin polypeptide.

[0040] like Figure 1-5 As shown: the recombinant human elastin described in the embodiments of the present invention is not limited to prokaryotic expression, but can also be expressed in eukaryotic cells, and there are no special requirements for the host and corresponding promoter for the expression of the recombinant surface protein.

[0041] like Figure 1 As shown: the multifunctional improved absorbable surgical suture described in the embodiment of the present invention is loaded on the absorbable suture by dopamine auto-oxidation and then mixed with other components. The protein and drug loading on the suture can be adjusted by the number and time of soaking in the dopamine solution, and the drug is one or more of antibacterial drugs and anti-scar drugs. The suture can be of different structures, such as barbs, spirals, etc.

[0042] In the embodiments of the present invention, the recombinant protein purification method and the corresponding purification connection tag are not limited.

[0043] The present invention will be further described below in conjunction with the embodiments. Example

[0044] Construction of expression plasmid of recombinant human elastin gene.

[0045] like Figure 2 As shown: obtain and optimize the complete gene or partial functional gene sequence of natural human elastin through the NCBI website, or independently involve human elastin, take the repeated sequence of natural elastin with partial functional domain or the repeated sequence of natural elastin polypeptide; then optimize the sequence for corresponding prokaryotic or eukaryotic expression preference, select appropriate restriction sites at both ends after optimization, send it to a third-party company for synthesis, and store the synthesized target gene in the corresponding prokaryotic or eukaryotic vector to obtain the expression plasmid construction of the recombinant human elastin gene.

[0046] In this embodiment, elastin-like protein is taken as an example. Example

[0047] Obtaining recombinant human elastin.

[0048] like Figure 3 As shown: the expression plasmid of the recombinant human elastin gene obtained in Example 1 was introduced into the competent cells of the Escherichia coli protein expression system by prokaryotic heat shock transformation (42°C water bath for 90 seconds), or introduced into the competent cells of the yeast expression system by electroporation.

[0049] In this embodiment, Escherichia coli was used as the synthetic host, and T7 or SP6 promoter was used as the promoter of the vector. After induction by 1 mM IPTG, overexpressed recombinant proteins were obtained, respectively. The recombinant proteins included: complete fragments of human elastin or protein fragments of partial functional gene; repeat proteins of natural elastin with partial functional domains or repeat protein fragments of natural elastin polypeptide; The obtained protein fragments were identified by SDS-PAGE / WB, purified, freeze-dried and stored; Pichia pastoris is used as a synthetic host, and a GAP or AOX1 promoter is used as a promoter of a vector. After induction by methanol or low temperature, overexpressed recombinant proteins are obtained respectively. The recombinant proteins include: a complete fragment of human elastin or a partial functional gene protein fragment; a repeat protein of a partial functional domain of natural elastin or a repeat protein fragment of a natural elastin polypeptide.

[0050] The obtained protein fragments were identified by SDS-PAGE / WB, purified, freeze-dried and stored. Example

[0051] Purification of recombinant human elastin like Figure 4As shown: the bacterial sludge obtained in large quantities in Example 2 can be lysed by bacterial cells. Before lysing, the bacterial cells are washed once with purified water, and the lysate is added to the collected bacterial cells at a ratio of 1:10-1:20 (w / v). After being fully suspended, high-pressure homogenization is performed, and then centrifuged at 8000 rpm for 30 minutes, and the supernatant is collected. The supernatant is purified by nickel column, and the purified protein is desalted with a dialysis bag. Then, it is freeze-dried and stored.

[0052] Lysis Buffer: 50 mM Tris, 0.5 mM EDTA, 50 mM NaCl, pH 8.0.

[0053] Dialysate: water. Example

[0054] Freeze-dried sample of recombinant human elastin like Figure 5 As shown: The freeze-dried sample in Example 2 was photographed with a mobile phone to obtain a macroscopic image. Figure 5 As shown in the figure, a porous and loose structure can be seen, presenting a three-dimensional porous network. Example

[0055] Acquisition and electron microscopic image of the multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan.

[0056] like Figure 6 As shown: First, the material was immersed in a dopamine solution (10 mM Tris buffer, pH = 8.5) and reacted in a 37°C constant temperature incubator for 24 hours to attach polydopamine (PDA) to the suture surface. Then, it was washed three times with ddH2O. In order to remove the unattached dopamine, each wash was ultrasonically treated for 5 minutes to obtain PDA@suture, which was then loaded with recombinant human elastin / triclosan / quercetin to obtain A (S-no loading); B (SD-loaded with dopamine); C (SDE-loaded with dopamine / recombinant human elastin); D (SDET-loaded with dopamine / recombinant human elastin / triclosan).

[0057] Take a small amount of sample and stick it on the electron microscope stage with the help of conductive glue, and then spray it with gold. It will be fully sprayed with gold in 90 seconds, and then move it to the electron microscope for shooting, and you can get the following picture: Figure 7 From the electron microscope photos, it can be seen that different loads will have different degrees of roughness. Example

[0058] Antibacterial evaluation of a novel multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan.

[0059] like Figure 8As shown: The new multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan obtained in Example 5 was subjected to the antibacterial zone experiment of Escherichia coli and Staphylococcus aureus, and the specific steps included activating bacteria, coating plates, placing samples, and photographing the antibacterial zone area at different time points. The control group was controlled by the unloaded absorbable suture. The results showed that the sutures in the triclosan-loaded group had a significant antibacterial zone compared with the other groups, and the antibacterial effect was still significant at different time points, showing that the improved sutures had a good antibacterial effect. Example

[0060] Cell biological evaluation of a novel multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan.

[0061] like Fig. 9 As shown: the new multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan obtained in Example 5 was cut into 2 mm small segments and immersed in culture medium. After 24 hours, the culture medium was taken to conduct a cell proliferation experiment. The results showed that the absorbable suture after loading showed good biocompatibility. Example

[0062] Effects of a novel multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan on skin tightening and scar removal.

[0063] like Fig.10 As shown: the multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan obtained in Example 5 was applied to pigs. After the fragrant pigs were raised in a common feeding room for a week to adapt to the environment, skin surgery was performed. An appropriate amount of sodium pentobarbital was injected into the ear vein for anesthesia. After anesthesia, the back and abdominal skin were disinfected with iodine tincture for standby use.

[0064] As shown in Figure 10-A: Use a sterile scalpel and ophthalmic forceps to make a small incision in the abdominal skin, and bury the multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan into the subcutaneous dermis. Then take pictures, and take pictures and samples after 7 days. The results show that the skin has a significant firming effect.

[0065] As shown in Figure 10-B: Use a sterile scalpel and ophthalmic forceps to make an incision of about 13-15 cm on the back, and use the multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan for suturing. Take pictures and take samples on the 12th day after surgery. The results show that suturing the skin with the multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan has a significant scar removal effect. Example

[0066] like Fig.11 As shown: After the pig skin samples obtained in Example 10 were fixed, the paraffin sections were stained with HE, MASSON and EVG to observe the inflammation and fibrous tissue growth. Taking the skin tightening application as an example, Fig.11 As shown in the enlarged image, there is no inflammation or fibrous tissue growth around the embedded sutures, which shows that the new multifunctional improved absorbable surgical suture loaded with recombinant human elastin / quercetin / triclosan has great potential in skin tightening and preventing inflammation.

Claims

1. A novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan, characterized in that: The method is obtained by loading absorbable sutures, dopamine, the antibacterial drug triclosan, recombinant human elastin and anti-scar drugs through biophysical and chemical methods. Dopamine is loaded on the absorbable sutures after auto-oxidation and then mixed with the antibacterial drug triclosan, recombinant human elastin and anti-scar drugs. The protein and drug loading on the sutures is adjusted by the number and time of immersion in the dopamine solution.

2. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The medicine is one or more of antibacterial medicine and anti-scar medicine.

3. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The sutures described are of different structures.

4. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The loading method is to self-oxidize dopamine into polydopamine, which specifically includes the following steps: first, immersing the material in a dopamine solution (10 mM Tris buffer, pH=8.5), reacting in a 37°C constant temperature incubator for 24 hours to attach polydopamine (PDA) to the surface of the suture, then washing three times with ddH2O, and performing ultrasonic treatment for 5 minutes each time to remove unattached dopamine to obtain PDA@suture, then soaking in a protein solution and a drug solution in turn, and then air-drying to obtain a multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan.

5. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The triclosan is a kind of antibacterial drug or a kind of antibacterial protein drug.

6. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The antibacterial drug is one of triclosan, ciprofloxacin, ofloxacin, rifampicin penicillin and amoxicillin.

7. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The quercetin is a kind of anti-scar drug.

8. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The recombinant human elastin component includes elastin and tag protein, wherein the tag protein that plays a purification role is one or more of HIS tag, SUMO tag or GST tag; wherein the elastin is a recombinant human full-length or partial functional domain natural elastin or a recombinant human elastin-like protein.

9. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The recombinant human elastin may be a recombinant human elastin-like protein, and the elastin-like protein may be a repeating sequence of a natural elastin protein in a partial functional domain or a repeating sequence of a natural elastin polypeptide.

10. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: Preparation of recombinant human elastin The following steps are involved: The following steps are involved: Step 1: Synthesize the designed recombinant human elastin gene sequence; Step 2: Double enzyme digestion of the synthesized gene fragment and the vector pET28a(+); Step 3: Recover the target fragment after double enzyme digestion by gel recovery; Step 4: Connect the recovered target fragments, then perform plate screening to obtain positive clones, and sequence to detect whether they are completely correct; Step 5: Shake the positive clones with correct sequencing and extract the plasmids, which are then introduced into competent E. coli (BL21(DE3)) by heat shock for plating culture. The competent cells can express proteins. Step 6: Pick the colonies after transformation and culture them. When the OD600 of the bacterial solution is 0.6-0.8, add IPTG inducer to induce for 4-6 hours. Then collect the bacterial solution and centrifuge to obtain bacterial sludge for use; Step 7: Lyse the bacterial sludge, ultrasonically disrupt it, and select different purification methods to separate and purify the protein according to whether the protein is in the supernatant or precipitate; Step 8: The purified protein is desalted and freeze-dried to obtain freeze-dried protein.

11. The novel multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan according to claim 1, characterized in that: The vector may also be selected from other prokaryotic expression vectors or eukaryotic expression vectors in vitro, and the expression host may be selected from prokaryotic cells and eukaryotic cells depending on the expression vector.

12. A new type of multifunctional absorbable surgical suture loaded with recombinant human elastin, quercetin and triclosan for use in skin tightening, wound healing and wound scar removal.